ClinicalTrials.gg
RecruitingNCT06477588J-RISEUpdated Nov 16, 2026

J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations

An interventional study of Health Navigation and Health Navigation, Employment Navigation plus Contingency Management Intervention in HIV, Contingency Management and Justice Involved Populations, sponsored by University of Chicago. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by University of Chicago · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare two interventions - Health Navigation and Health Navigation Plus among individuals who have been impacted by the criminal legal system.

The main question it aims to answer is:

  • Compared with the Health Navigation group, are participants in the Health Navigation Plus group more likely to a) access HIV care, treatment, and prevention services and employment services and b) access employment services and be employed in community?

Participants on the study will be:

  • Randomly assigned (like a flip of a coin) to participate in either Health Navigation or Health Navigation Plus. Participants will have an equal chance of being placed in either group.
  • Complete three surveys over the course of 13 months
  • Participants in the Health Navigation group will have two in person meetings and seven check-ins with the health navigator over 6 months
  • Participants in the Health Navigation Plus group will have two in person meetings and seven check-ins with the health navigator over 6 months, two in person and 10 check ins with the employment navigator over 12 months and up to $200 to support employment and career development needs and receive up to $140 to support health goals. Samples of blood, urine and swabs may be collected to meet the health goals.
Read the detailed description

The overarching goals of J-RISE is to evaluate the effectiveness and implementation of two packaged status neutral interventions to improve access to HIV and employment-related services and employment among individuals who have been impacted by the criminal legal system. Criminal legal involved individuals are particularly vulnerable to HIV, and oftentimes experience delayed uptake and benefit from available HIV services. Status neutral interventions for criminal legal involved individuals hold significant promise in supporting Ending the HIV Epidemic (EHE) plans including enhancing access to HIV, mental health, and substance use services post-release; expanding the skills of the HIV workforce; and addressing the social and structural barriers to HIV services (e.g., unemployment) experienced by this population. The underlying tenet of status neutral interventions is a holistic or whole person approach to service delivery that meets the needs of clients regardless of their HIV status. There is a dearth of implementation science research in this domain, generally, and specifically for criminal legal involved individuals. The following status neutral evidenced-informed/promising interventions will be implemented to improve HIV, pre-exposure prophylaxis (PrEP), and employment-related outcomes: (1) Health Navigation (HN) - leading with status neutral health navigator, a foundational intervention, to enhance access to HIV, mental health, substance use, and other supportive services; followed by (2) Employment navigation (EN) -status neutral employment navigators dedicated to supporting client employment, training, and career development needs; and coupled with (3) Contingency Management Intervention (CMI) - the provision of financial incentives for the uptake and achievement of specific HIV care and prevention milestones. Bringing these interventions together will maximize their independent effectiveness and provide significant promise for addressing the social and structural barriers to HIV services. J-RISE will be guided by robust implementation science and equity frameworks (i.e., CFIR: Consolidated Framework for Implementation Research, RE-AIM: Reach Effectiveness Adoption Implementation Maintenance, and MIPA: Meaningful Involvement of People Living with and Impacted by HIV) and tools (e.g., implementation outcomes crosswalk and implementation research logic model). The implementation evaluation will study seven proposed implementation strategies: (1) Building a cross-site learning collaborative; (2) conducting readiness assessments; (3) providing cross-site training for the status-neutral interventions; (4) facilitating ongoing calls with interventionists; (5) monitoring financial incentives; (6) conducting audit and feedback to support implementation; and (7) engaging clients and consumers in the intervention.

Study Aim:

Aim 1. Evaluate the effectiveness of two packaged status neutral interventions (Health Navigation versus Health Navigation + Employment Navigation + Contingency Management Intervention) on primary outcomes (i.e., linkages to HIV, PrEP, and employment-related services within 90 days) and secondary outcomes (i.e., receipt of HIV/STI testing, receipt of mental health and substance use services, retention in HIV and PrEP care, viral suppression, employment within 180 days and sustained employment) among enrolled participants. The investigators will conduct a pragmatic 2-arm randomized control trial (RCT) with N=350 enrolled participants randomized 1:1.

Aim 2. Explore the deployment of seven prioritized implementation strategies to enhance the adoption, implementation, and sustainment of the packaged status neutral interventions as it relates to nine key implementation outcomes (i.e., reach, acceptability, feasibility, adoption, fidelity, penetration, effectiveness, cost, engagement, and sustainability). The investigators will utilize a mixed method approach to complete this aim.

02

Conditions studied

  • HIV
  • Contingency Management
  • Justice Involved Populations
  • Status Neutral Interventions
  • Mental Health
  • Substance Use

Browse trials for

Keywords

  • HIV
  • Contingency management
  • Justice involved populations
  • Status neutral interventions
  • mental health
  • substance use
  • employment
  • PrEP
03

In context

Psychological Well-Being Unverified

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

This study's planned enrollment of 350 is above the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

University of Chicago is the lead sponsor of 926 studies on the registry; 187 are open to participants now.

Of its 103 completed or terminated interventional studies of FDA-regulated products, 72 (70%) have results posted.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. be at least 18 years of age;
  2. currently reside or intend to reside in one of the study communities (i.e., Cook County, Baton Rouge, and the New Orleans area);
  3. be able to provide in English and complete the study in English. In addition, potential participants must:
  4. be currently incarcerated in jail or prison and report an expected release within 90 days, or under community supervision or drug court, or report a recent incarceration within the last three years, or in the last 12 months has had an interaction with law enforcement that did not lead to an arrest or jail or prison time, AND has not already been linked and/or retained in or PrEP care in the community;
  5. report needing employment-related services; and
  6. have a confirmed HIV positive or negative status (within 90 days of enrollment) and if HIV negative meets one of CDC's PrEP indications (i.e., sexually active, needle sharing, previous STI history in the last 24 months) or plans to have sex in the next 12 months or wants more information about PrEP.

Exclusion criteria

Exclusion Criteria:

  1. unwilling/unable to provide ,
  2. does not live or intend to live in one of the study locations,
  3. unable to confirm status,
  4. unable to conduct the study in English, and
  5. currently enrolled in another intervention to support HIV care, PrEP care, and economic stability.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (estimated)

Study arms

  • Active comparator
    Health Navigation

    Referrals to HIV, mental health, substance use, and other supportive services

    Behavioral: Health Navigation

  • Experimental
    Health Navigation, Employment Navigation plus Contingency Management Intervention

    Referrals to HIV, mental health, substance use, and other supportive services Referrals for employment including training, and career development needs; Provision of financial incentives for the uptake and achievement of specific HIV care and prevention milestones.

    Behavioral: Health Navigation, Employment Navigation plus Contingency Management Intervention

Interventions

  • BehavioralHealth Navigation

    Participants meet with Health Navigator twice in-person and receive 7 check-ins from the Health Navigator over a 6 month period. The health navigator provides participants with referrals and support to HIV, mental health, substance use, and other supportive services

  • BehavioralHealth Navigation, Employment Navigation plus Contingency Management Intervention

    Participants meet with health navigator twice in-person and receive 7 check-ins from the health navigator over a 6 month period. The health navigator provides participants with referrals and support to HIV, mental health, substance use, and other supportive services. Participants meeting with the employment navigator twice in-person and receive 10 check-ins from the employment navigator over 12 months. The employment navigator provides participants with referrals to employment and career development opportunities in the community and up to $200 for employment and career development support (e.g., transportation to interview, GED preparation course). Participants also receive up to $140 for HIV/STI care, treatment, and prevention milestones as part of the contingency management interview over a period of 12 months.

06

What researchers measure

Primary outcomes

  1. Linkage to HIV care

    Number of participants who visit a provider for HIV care and receive a prescription based on medical reports

    Time frame: Baseline through 90 days in community

  2. Linkage to PrEP care

    Number of participants who visit a provider for PrEP care ranging from PrEP information only to the receipt of a prescription based on medical reports

    Time frame: Baseline through 90 days in community

  3. Linkage to employment-related services in community

    Number of referred participants who receive employment-related service in the community based on referral reports completed by the interventionists

    Time frame: Baseline through 90 days in community

Secondary outcomes

  1. Retention in HIV care

    Number of participants who attend two HIV care visits at least 90 days apart based on medical reports

    Time frame: 12 months

  2. HIV viral suppression

    Number of participants with an HIV viral load \< 200 copies/ml based on medical reports

    Time frame: Baseline through 12 months

  3. Retention in PrEP care

    Number of participants with at least two PrEP care visits in a 12-month period based on medical reports

    Time frame: 12 months

  4. Receipt of mental health services

    Number of participants with a mental health service visit within 180 days based on referrals reported complete by interventionists.

    Time frame: Baseline through 180 days in community

  5. Receipt of substance use services

    Number of participants with a substance use visit within 180 days based on referrals reported complete by interventionists.

    Time frame: Baseline through 180 days in community

  6. Employment

    Number of employment seeking participants who self-report on surveys being employed

    Time frame: Baseline through 180 days in community

  7. Sustained employment

    Number of participants who self-report in surveys maintaining employment for at least 3 months within a 12-month period

    Time frame: 12 months

Other outcomes

  1. Receipt of other HIV prevention services

    Number of participants who self-report in surveys receiving a HIV/STI Test, nonoccupational HIV post-exposure prophylaxis (nPEP), and/or Doxycycline post-exposure prophylaxis (DoxyPEP)

    Time frame: Baseline through 12 months

  2. Changes in employer and temporary staffing agency policies and practices

    Number and types of observed policies and practices related to hiring returned citizens over the course of the study based on email correspondence and informal conversations with employers and temporary staffing agencies.

    Time frame: Baseline through 12 months

  3. Changes in housing status

    Number of participants who self-report stable housing

    Time frame: Baseline through 12 months

  4. Changes in substance use behaviors

    Number of participants who self-report substance use behaviors

    Time frame: Baseline through 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The J-RISE project will share individual level data of common data elements, with identifiers removed, with the SISCI coordinating center. Definitions and codebooks for all common data elements will be provided by the SISCI coordinating center, along with standardized survey items and qualitative questions where possible. All data submitted to the SISCI coordinating center will be deposited to Northwestern University's ARCH repository at the end of the performance period; de-identified survey data will be submitted to the National Institute of Mental Health Data Archive (NDA) at the National Institutes of Health (NIH). De-identified data will be shared with outside entities at the end of the study upon publication of the planned protocol and primary outcomes papers.

Supporting information: Study protocol, Analytic code

Time frame: Data will be shared biannually on July 15 and December 1 from 2024-2028. All data submitted to the SISCI coordinating center will be deposited to Northwestern University's ARCH repository at the end of the performance period; de-identified survey data will be submitted to the National Institute of Mental Health Data Archive (NDA) at the National Institutes of Health (NIH). De-identified data will be shared with outside entities at the end of the study upon publication of the planned protocol and primary outcomes papers.

Access criteria: Any investigator may propose research questions and manuscript ideas. For external investigators, the SISCI coordinating center will determine whether a data use agreement is needed that will regulate sharing of de-identified data. PIs will be able to opt in to data sharing on a case-by-case basis upon reviewing the proposal. Through this mechanism, the University of Chicago will make data available to users under data sharing agreements that meet the following criteria: A commitment to using the data only for research purposes and not to identify any individual participant A commitment to securing the data using appropriate transfer and storage protections A commitment to destroying or returning the data after analyses are completed A commitment to acknowledging the source (i.e. parent study) of the data

Data sharing details ↗ · arch.library.northwestern.edu

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Jun 2028, 46 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 46 months is above that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2024
First posted
Jun 27, 2024
StartActual
Aug 13, 2024
Primary completionEst.
Jun 30, 2028
CompletionEst.
Jun 30, 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06477588
Collaborators
Northwestern University, NORC at the University of Chicago, Frontline Legal Services, Capitol Area Reentry Program Inc., National Institute of Mental Health (NIMH), Cook County Health
Responsible party
Sponsor
First posted
Jun 27, 2024
Start date
Aug 13, 2024
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Jeannette Webb
Contact
jwebb9@bsd.uchicago.edu
773-834-5795
Mainza Durrell, DrPH
Contact
mdurrell@bsd.uchicago.edu
773-702-7589
Russell Brewer, DrPH
principal investigator · University of Chicago

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion